204 related articles for article (PubMed ID: 15841777)
1. Diversity of urinary symptoms in patients tentatively diagnosed with benign prostatic hyperplasia referred to a urologic clinic in Norway.
Haltbakk J; Hanestad BR; Hunskaar S
Scand J Urol Nephrol; 2004; 38(6):454-61. PubMed ID: 15841777
[TBL] [Abstract][Full Text] [Related]
2. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
Haltbakk J; Hanestad BR; Hunskaar S
BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
[TBL] [Abstract][Full Text] [Related]
3. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of a "Single Question Nocturia Score" compared to the "International Prostate Symptoms Score" in the evaluation of lower urinary tract symptoms in benign prostatic hyperplasia: A study performed at Ndola Teaching Hospital, Ndola, Zambia.
Kajimotu T; Bowa K
PLoS One; 2018; 13(6):e0198096. PubMed ID: 29944653
[TBL] [Abstract][Full Text] [Related]
5. How important are men's lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)?
Haltbakk J; Hanestad BR; Hunskaar S
Qual Life Res; 2005 Sep; 14(7):1733-41. PubMed ID: 16119184
[TBL] [Abstract][Full Text] [Related]
6. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
Jhang JF; Liao CH; Kuo HC
Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
[TBL] [Abstract][Full Text] [Related]
7. The 10-item LURN Symptom Index (LURN SI-10) Detects Additional Symptoms and Shows Convergent Validity With the IPSS in Men Presenting With Lower Urinary Tract Symptoms.
Glaser AP; Kristof TW; Judge C; Javitch G; Hirsch S; Talaty P; Helfand BT; Smith AR; Griffith JW
Urology; 2023 Jan; 171():184-189. PubMed ID: 36370771
[TBL] [Abstract][Full Text] [Related]
8. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Rosen RC; Fitzpatrick JM;
BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.
Trueman P; Hood SC; Nayak US; Mrazek MF
BJU Int; 1999 Mar; 83(4):410-5. PubMed ID: 10210562
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
11. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
12. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
13. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
14. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
[TBL] [Abstract][Full Text] [Related]
15. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
[TBL] [Abstract][Full Text] [Related]
16. Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence.
Roberts RO; Jacobsen SJ; Jacobson DJ; Reilly WT; Talley NJ; Lieber MM
Urology; 1998 Feb; 51(2):213-9. PubMed ID: 9495700
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer.
Grivas N; van der Roest R; Tillier C; Schouten D; van Muilekom E; Schoots I; van der Poel H; Heijmink S
Urology; 2017 Sep; 107():196-201. PubMed ID: 28601562
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.
Bechara A; Casabe A; Rodriguez Baigorri G; Cobreros C
J Sex Med; 2014 Feb; 11(2):498-505. PubMed ID: 24224728
[TBL] [Abstract][Full Text] [Related]
19. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
[TBL] [Abstract][Full Text] [Related]
20. Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
María Molero J; Miñana B; Palacios-Moreno JM; Téllez Martínez-Fornes M; Lorite Mingot D; Agra Rolán A; Carreño Á; Cuervo Pinto R
Int J Clin Pract; 2020 Nov; 74(11):e13602. PubMed ID: 32609933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]